Objective. The specificity of the autoantibody response in different autoim
mune diseases makes autoantibodies useful for diagnostic purposes. It also
focuses attention on tissue- and event-specific circumstances that may sele
ct unique molecules for an autoimmune response in specific diseases. Defini
ng additional phenotype-specific autoantibodies may identify such circumsta
nces. This study was undertaken to investigate the disease specificity of P
MS1, an autoantigen previously identified in some sera from patients with m
yositis.
Methods. We used immunoprecipitation analysis to determine the frequency of
autoantibodies to PMS1 in sera from patients with myositis, systemic lupus
erythematosus, or scleroderma and from healthy controls. Additional antige
ns recognized by PMS1-positive sera were further characterized in terms of
their susceptibility to cleavage by apoptotic proteases.
Results. PMS1, a DNA mismatch repair enzyme, was identified as a myositis-s
pecific autoantigen. Autoantibodies to PMS1 were found in 4 of 53 patients
with autoimmune myositis (7.5%), but in no sera from 94 patients with other
systemic autoimmune diseases (P = 0.016). Additional mismatch repair enzym
es (PMS2, MLH1) were targeted, apparently independently. Sera recognizing P
MS1 also recognized several other proteins involved in DNA repair and remod
eling, including poly (ADP-ribose) polymerase, DNA-dependent protein kinase
, and Mi-2. All of these autoantigens were efficiently cleaved by granzyme
B, generating unique fragments not observed during other forms of cell deat
h.
Conclusion. PMS1 autoantibodies are myositis specific. The striking correla
tion between an immune response to a group of granzyme B substrates (functi
oning in DNA repair and remodeling) and the myositis phenotype strongly imp
lies that tissue- and event-specific biochemical events play a role in sele
cting these molecules for an autoimmune response. Understanding the role of
granzyme B cleavage in this response is an important priority.